Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katrina M Pollock

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Plos One|January 13, 2016
PD-1 Expression and Cytokine Secretion Profiles of Mycobacterium tuberculosis-Specific CD4+ T-Cell Subsets; Potential Correlates of Containment in HIV-TB Co-InfectionKatrina M Pollock, Damien J Montamat-Sicotte, Lisa Grass, et al.
The Journal of Infectious Diseases|August 23, 2013
T-cell immunophenotyping distinguishes active from latent tuberculosisKatrina M Pollock, Hilary S Whitworth, Damien J Montamat-Sicotte, et al.
Plos Biology|June 20, 2025
Two distinct subpopulations of human stem-like memory T cells exhibit complementary roles in self-renewal and clonal longevityDanai Koftori, Charandeep Kaur, Laura Mora Bitria, et al.
Plos Pathogens|October 4, 2022
Enhanced immune responses following heterologous vaccination with self-amplifying RNA and mRNA COVID-19 vaccinesTamara Elliott, Hannah M Cheeseman, Abbey B Evans, et al.
Frontiers in Immunology|October 24, 2022
Comparison of blood and lymph node cells after intramuscular injection with HIV envelope immunogensSuzanne Day, Charandeep Kaur, Hannah M Cheeseman, et al.
Nature Communications|December 5, 2023
Early mucosal events promote distinct mucosal and systemic antibody responses to live attenuated influenza vaccineRyan S Thwaites, Ashley S S Uruchurtu, Victor Augusti Negri, et al.
Clinical and Translational Science|October 20, 2021
Incidental findings in UK healthy volunteers screened for a COVID-19 vaccine trialSusanne H Hodgson, Poppy Iveson, Jessica Larwood, et al.
Ebiomedicine|January 3, 2025
Experimental medicine study with stabilised native-like HIV-1 Env immunogens drives long-term antibody responses, but lacks neutralising breadthKatrina M Pollock, Hannah M Cheeseman, Leon R McFarlane, et al.
British Journal of Clinical Pharmacology|November 28, 2022
The effect of TRV027 on coagulation in COVID-19: A pilot randomized, placebo-controlled trialAlexander J Robbins, Nur Amalina Che Bakri, Edward Toke-Bjolgerud, et al.
The Lancet. Gastroenterology & Hepatology|December 8, 2022
Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort studyZhigang Liu, Kaixing Le, Xin Zhou, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Plos One|January 13, 2016
PD-1 Expression and Cytokine Secretion Profiles of Mycobacterium tuberculosis-Specific CD4+ T-Cell Subsets; Potential Correlates of Containment in HIV-TB Co-InfectionKatrina M Pollock, Damien J Montamat-Sicotte, Lisa Grass, et al.
The Journal of Infectious Diseases|August 23, 2013
T-cell immunophenotyping distinguishes active from latent tuberculosisKatrina M Pollock, Hilary S Whitworth, Damien J Montamat-Sicotte, et al.
Plos Biology|June 20, 2025
Two distinct subpopulations of human stem-like memory T cells exhibit complementary roles in self-renewal and clonal longevityDanai Koftori, Charandeep Kaur, Laura Mora Bitria, et al.
Plos Pathogens|October 4, 2022
Enhanced immune responses following heterologous vaccination with self-amplifying RNA and mRNA COVID-19 vaccinesTamara Elliott, Hannah M Cheeseman, Abbey B Evans, et al.
Frontiers in Immunology|October 24, 2022
Comparison of blood and lymph node cells after intramuscular injection with HIV envelope immunogensSuzanne Day, Charandeep Kaur, Hannah M Cheeseman, et al.
Nature Communications|December 5, 2023
Early mucosal events promote distinct mucosal and systemic antibody responses to live attenuated influenza vaccineRyan S Thwaites, Ashley S S Uruchurtu, Victor Augusti Negri, et al.
Clinical and Translational Science|October 20, 2021
Incidental findings in UK healthy volunteers screened for a COVID-19 vaccine trialSusanne H Hodgson, Poppy Iveson, Jessica Larwood, et al.
Ebiomedicine|January 3, 2025
Experimental medicine study with stabilised native-like HIV-1 Env immunogens drives long-term antibody responses, but lacks neutralising breadthKatrina M Pollock, Hannah M Cheeseman, Leon R McFarlane, et al.
British Journal of Clinical Pharmacology|November 28, 2022
The effect of TRV027 on coagulation in COVID-19: A pilot randomized, placebo-controlled trialAlexander J Robbins, Nur Amalina Che Bakri, Edward Toke-Bjolgerud, et al.
The Lancet. Gastroenterology & Hepatology|December 8, 2022
Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort studyZhigang Liu, Kaixing Le, Xin Zhou, et al.
Pageof 4